Tetherex raises $50M series B, plans Phase II for pan-selectin inhibitor

By Jennie Walters | Apr 20, 2018 | 7:35 PM GMT

Tetherex Pharmaceuticals Inc. (Oklahoma City, Okla.) said it closed a $50 million series B round on April 18 led by existing investor MPM Capital. I2E, Tetherex board